5 results
424B5
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus supplement for primary offering
4:07pm
product candidates;
our ability to quickly and efficiently identify and develop additional product candidates and to innovate with respect to our … to quickly and efficiently identify and develop additional product candidates and to innovate with respect to our existing or future antibody drug
POS AM
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus update (post-effective amendment)
4:05pm
and efficiently identify and develop additional product candidates and to innovate with respect to our existing or future antibody drug candidate platforms;
our
POSASR
MRSN
Mersana Therapeutics Inc
28 Feb 24
Automatic shelf registration (post-effective amendment)
8:43am
and to innovate with respect to our existing or future antibody drug candidate platforms;
our ability to advance any product candidate into, and successfully
- Prev
- 1
- Next